Duck cornea epithelial cell suspension cell strain as well as construction method and application thereof

By developing duck eye cornea epithelial cell line, the problems of long chicken embryo cycle, high cost and unstable quality in the production of existing avian vaccines have been solved, efficient and stable production of avian virus vaccines has been achieved, and suitable for large-scale production has been provided. Duck-derived cell suspension culture medium.

CN118956732AActive Publication Date: 2024-11-15GUANGZHOU BAISAI BIOMEDICAL TECHNOLOGY CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411276253.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-15
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

The existing avian vaccine production technology has a long culture cycle, cumbersome operation steps, high cost and potential risk of virus contamination. The cultivation of primary avian cell requires fresh cells, and the quality between production batches is inconsistent, the virus yield of passaged cell culture has decreased, and heterologous cells are The vaccine is poor, and the lack of duck-derived cell lines leads to low production efficiency of avian virus vaccines.

Method used

A duck eye cornea epithelial cell line was developed, named DCE-S, a corneal epithelial suspension cell of Madak eye. By isolating duck embryonic eyeballs, the serum concentration of fetal bovine was gradually reduced, and the serum-free suspension cell line was passed on to large-scale production. Avian virus vaccine.

Benefits of technology

It provides duck eye corneal epithelial cell lines that are easy to culture, fast growth and stable passage, which are used for avian virus culture, isolation and vaccine production, reducing production costs and improving the batch consistency and safety of viral vaccines.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005040270820000011
    Figure HDA0005040270820000011
  • Figure HDA0005040270820000012
    Figure HDA0005040270820000012
  • Figure HDA0005040270820000013
    Figure HDA0005040270820000013
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and particularly relates to a duck cornea epithelial cell suspension cell strain and a construction method and application thereof. According to the shelduck cornea epithelium suspension cell DCE-S, adult cornea epithelium cells are separated from ducks for the first time and are successfully subjected to suspension domestication, the shelduck cornea epithelium suspension cell DCE-S is named as shelduck cornea epithelium suspension cell DCE-S, and the shelduck cornea epithelium suspension cell DCE-S is preserved in China Center for Type Culture Collection in Wuhan University, Wuhan, China on June 28, 2024, and the preservation number is CCTCC NO: C2024189. The cell strain is easy to culture, relatively high in growth speed, stable in passage, high in cell density (up to 6-8 * 10 < 6 > cells / mL), monodisperse in growth, full in form, uniform in size and high in cell viability, and is suitable for serum-free suspension culture of a bioreactor. The cell strain can be used for culturing, separating and detecting poultry viruses, preparing poultry vaccines and screening medicines for preventing or treating diseases caused by poultry virus infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and specifically relates to a duck corneal epithelial cell suspension strain and a construction method and application thereof. Background Art

[0002] my country is a major producer and consumer of meat ducks, producing and consuming more than 3 billion meat ducks each year, accounting for more than 70% of the global meat duck sales, with an annual output value of more than 100 billion yuan. With the increase in breeding volume, poultry diseases occur frequently, including avian influenza (H5, H7 and H9 subtypes), duck plague, duck viral hepatitis, Muscovy duck and gosling plague, Muscovy duck parvovirus disease, duck parvovirus disease, duck coronavirus enteritis, duck pox, Muscovy duck reovirus disease, new duck reovirus disease, duck paramyxovirus disease, duck circo, duck Tembusu virus disease and other new viral infectious diseases, which are the most serious diseases endangering waterfowl farming industry and seriously restrict the development of poultry farming industry.

[0003] Vaccine immunization is the most effective means to prevent animal diseases. The production of poultry vaccines in China mainly relies on chicken embryo culture technology, poultry primary cell culture technology, and serial cell culture technology. Among them, the chicken embryo culture process has a long culture cycle, cumbersome operation steps, and high production cost. There are problems of unstable chicken embryo quality and potential exogenous virus contamination during large-scale production. After harvesting, waste embryos are difficult to be harmlessly treated, and there are risks of virus spread and environmental pollution. The poultry primary cell culture process requires fresh primary cells to be prepared each time, and viral vaccines can only be produced through the adherent culture process. On the one hand, serum is required to maintain the culture, which is costly; on the other hand, the scale is limited, and the virus yield is reduced due to the limitation of the matrix surface area, which is easy to contaminate and inconsistent in quality between batches. In the serial cell culture process, the existing cell-derived vaccines mainly use heterologous cells (such as canine kidney cells (MDCK suspension cells) to culture avian influenza virus) as the culture matrix for virus production, and the vaccine immunization effect is slightly worse than that of chicken embryo culture.

[0004] There are few research and development results of poultry cells in China, and there is no commercial duck-derived cell line. In order to better and more effectively separate, proliferate and produce poultry viruses, develop waterfowl-specific vaccines, and prevent disease outbreaks, it is of great significance to develop a duck-derived cell suspension cell line suitable for industrial large-scale production.

[0005] Application No. 202111338851.3 "Goose retinal epithelial cell line, its construction method and application" mainly obtains a low-serum adherent culture type goose retinal epithelial cell line, which is not a duck-derived cell line and cannot be cultured in serum-free suspension.

[0006] Application No. 202210113778.8 "Pig retinal epithelial cell line, its construction method and application" mainly obtains a pig retinal epithelial cell line, which is not a duck cell line and cannot be cultured in serum-free suspension. Summary of the invention

[0007] The first aspect of the present invention aims to provide a cell line.

[0008] The purpose of the second aspect of the present invention is to provide a method for constructing the cell line of the first aspect of the present invention.

[0009] The third aspect of the present invention aims to provide an application.

[0010] The fourth aspect of the present invention aims to provide a method for culturing viruses.

[0011] The fifth aspect of the present invention aims to provide a method for producing a viral vaccine.

[0012] The sixth aspect of the present invention aims to provide a viral vaccine.

[0013] In order to achieve the above-mentioned purpose of the present invention, the technical solution adopted by the present invention is:

[0014] The first aspect of the present invention provides a duck corneal epithelial cell line, named shelduck corneal epithelial suspension cell DCE-S (shelduck), which was deposited in the China Center for Type Culture Collection located at Wuhan University, Wuhan, China on June 28, 2024, with a deposit number of CCTCC NO: C2024189.

[0015] The second aspect of the present invention provides a method for constructing a duck corneal epithelial cell line according to the first aspect of the present invention, comprising the following steps:

[0016] 1) Separate the eyeball of the duck embryo, separate the cornea, and cut it into tissue blocks;

[0017] 2) Add the first culture medium, mix well, culture, and subculture for 5 to 15 generations;

[0018] 3) Cultivate with the second culture medium and pass it for 3 to 5 generations;

[0019] 4) using the third medium for culturing and subculturing for 3 to 5 generations;

[0020] 5) Use the fourth medium for culturing and subculture for 3 to 5 generations.

[0021] 6) Cultivate in serum-free suspension medium and subculture for 20 to 30 generations to obtain.

[0022] Preferably, the first culture medium comprises 8-10 v / v% fetal bovine serum and a basal culture medium.

[0023] Preferably, the second culture medium comprises 6-8 v / v% fetal bovine serum and a basal culture medium.

[0024] Preferably, the third culture medium comprises 4-6 v / v% fetal bovine serum and a basal culture medium.

[0025] Preferably, the fourth culture medium comprises 2-3 v / v% fetal bovine serum and a basal culture medium.

[0026] Preferably, the basal culture medium includes at least one of MEM culture medium, DMEM culture medium and DMEM / F12 culture medium.

[0027] In some embodiments of the present invention, the construction method comprises: 1) taking 3 duck embryos aged 7 to 11 days, separating the eyeballs with ophthalmic scissors, placing them in a clean sterile dish, washing them with pre-cooled D-Hank's solution for 3 times, separating the cornea, cutting them into pieces, adding a small amount of MEM containing 8 to 10 v / v% fetal bovine serum, blowing and breaking the tissue blocks, and transferring them to a culture bottle for culture at 37°C and a 5% CO2 incubator; 2) 12 to 24 hours after cell separation and culture, gently shaking the cell bottle, discarding the supernatant, leaving only the cells that have attached to the wall, and adding fresh 8 ~10v / v% fetal bovine serum in MEM, and continue to culture; when the cells grow into a monolayer, digest them with 0.25wt% EDTA-trypsin to reduce them to single cells, and then inoculate them into a 96-well plate at an average density of 0.5 cells / well, mark the wells where single cells are inoculated, and when the cells in these single cell wells grow into clones, a duck corneal epithelial single cell strain can be obtained, which is continuously passaged for more than 10 generations; 3) Cultivate in MEM medium containing 6~8v / v% fetal bovine serum, and the culture conditions are 37°C, 5% CO2 incubator. After continuous culture for 3 to 5 generations, the cells were cultured in a MEM medium containing 4 to 6 v / v% fetal bovine serum; after continuous culture for 3 to 5 generations, the cells were cultured in a MEM medium containing 2 to 3 v / v% fetal bovine serum; after continuous culture for 3 to 5 generations, low-serum adherent culture type duck corneal epithelial cells were obtained; 4) the low-serum adherent culture type duck corneal epithelial cells were grown into a monolayer, digested with 0.25 wt% EDTA-trypsin, the cell suspension was collected, centrifuged at 800 to 1000 rpm for 6 minutes, the supernatant was discarded, the cell pellet was retained, the cell pellet was resuspended with a serum-free suspension medium, and the cell density was adjusted to 1.0×10 6 cells / mL, culture conditions were 37°C, 5% CO2, 100-130r / min shaking. Samples were taken every 24 hours to observe cell morphology and count. After 2-3 days of culture, the cells were centrifuged and the medium was changed for subculture until the cell number of each generation was ≥6.0×10 6The cells were stably and continuously cultured for more than 30 generations, and serum-free fully suspended cultured duck corneal epithelial cells, i.e., duck corneal epithelial cell suspension cell line, were obtained.

[0028] Preferably, the size of the tissue fragments in step 1) is 1 to 2 cm 3 / indivual.

[0029] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0030] The third aspect of the present invention is to provide the use of the duck corneal epithelial cell line of the first aspect of the present invention in any one of 1) to 8):

[0031] 1) Cultivate the virus;

[0032] 2) Preparation of products for cultured viruses;

[0033] 3) Isolation of viruses;

[0034] 4) Preparation of virus isolation products;

[0035] 5) Virus testing for non-diagnostic treatment destinations;

[0036] 6) Preparation of products for detecting viruses;

[0037] 7) Preparation of viral vaccines;

[0038] 8) Drug screening;

[0039] The medicine is a medicine used for preventing or treating diseases caused by viral infection.

[0040] Preferably, the virus comprises at least one of avian influenza virus, duck circovirus, and duck Tembusu virus.

[0041] Preferably, the avian influenza virus comprises an H9 subtype avian influenza virus.

[0042] The fourth aspect of the present invention provides a method for culturing viruses, comprising inoculating the viruses into the duck corneal epithelial cell line of the first aspect of the present invention and culturing the cells.

[0043] Preferably, the virus comprises at least one of avian influenza virus, duck circovirus, and duck Tembusu virus.

[0044] Preferably, the avian influenza virus comprises an H9 subtype avian influenza virus.

[0045] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0046] The fifth aspect of the present invention provides a method for preparing a viral vaccine, comprising inoculating the virus into the duck corneal epithelial cell line of the first aspect of the present invention, culturing, and inactivating to obtain the viral vaccine.

[0047] Preferably, the virus comprises at least one of avian influenza virus, duck circovirus, and duck Tembusu virus.

[0048] Preferably, the avian influenza virus comprises an H9 subtype avian influenza virus.

[0049] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0050] The sixth aspect of the present invention provides a viral vaccine prepared by the method of the fifth aspect of the present invention.

[0051] The beneficial effects of the present invention are:

[0052] Through the extensive creative work of the inventors, the present invention isolated and obtained duck corneal epithelial cells from ducks for the first time, and successfully suspended and domesticated them, providing a duck corneal epithelial cell line named duck corneal epithelial suspension cell DCE-S, which was deposited in the China Center for Type Culture Collection at Wuhan University, Wuhan, China on June 28, 2024, with the deposit number CCTCCNO: C2024189. The cell line is easy to culture, grows fast, can be stably propagated, and has a high cell density of 6 to 8×10 6 cells / mL, with single dispersed growth, full morphology, uniform size, high cell viability, and suitable for serum-free suspension culture in bioreactors. This cell line can be used to culture, isolate, and detect avian viruses, prepare avian vaccines, and screen drugs for preventing or treating diseases caused by avian virus infection. This cell line provides an important culture matrix for large-scale suspension culture of avian vaccines and for reducing costs and increasing efficiency. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] The present invention will be further described below with reference to the accompanying drawings and embodiments, wherein:

[0054] Figure 1 These are the low-serum adherent cultured duck corneal epithelial cells in Example 1; the left side shows the results after 24 hours of culture, and the right side shows the results after 48 hours of culture.

[0055] Figure 2 The results show the growth status of the 25th generation of corneal epithelial suspension cells DCE-S from the eyes of shelduck.

[0056] Figure 3This is the stable passage of different generations of duck corneal epithelial suspension cells DCE-S (F9~F30).

[0057] Figure 4 The cytopathic effect of DCE-S, a suspension cell of corneal epithelium of Mallard duck, inoculated with H9 subtype avian influenza virus for 72 hours.

[0058] Figure 5 The cytopathic effect of duck corneal epithelial suspension cells DCE-S inoculated with duck circovirus for 60 hours.

[0059] Figure 6 The cytopathic effect of duck corneal epithelial suspension cells DCE-S inoculated with duck Tembusu virus for 50 hours. DETAILED DESCRIPTION

[0060] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0061] Example 1 Construction of duck corneal epithelial cell suspension strain

[0062] 1. Rapid isolation and culture of primary duck corneal epithelial cells

[0063] (1) Take a 10-day-old duck embryo, examine it, and draw the air cell boundaries and fetal position;

[0064] (2) Disinfect the embryonated egg with 75% alcohol, and on a sterile operating table, gently break the eggshell at the air chamber with sterile tweezers and remove it, tear off the shell membrane at the air chamber with another pair of sterile tweezers, and then use another pair of sterile tweezers to remove the embryo and place it in a sterile dish;

[0065] (3) Separate the eyeball with ophthalmic scissors, place it in a clean sterile dish, wash it three times with pre-cooled D-Hank's solution, separate the cornea, cut it into pieces, add a small amount of MEM containing 10 v / v% fetal bovine serum, blow and break the tissue pieces, and transfer it to a culture bottle for culture at 37°C and 5% CO2 incubator;

[0066] (4) 24 h after cell isolation and culture, gently shake the cell bottle, discard the supernatant, leaving only the cells that have attached to the wall, add fresh MEM containing 10% fetal bovine serum, and continue culturing;

[0067] (5) After the cells grow into a monolayer, they are digested with 0.25wt% EDTA-trypsin to reduce them to single cells. Then, they are inoculated into a 96-well plate at an average density of 0.5 cells / well. The wells inoculated with single cells are marked. After the cells in these single cell wells grow into clones, duck eye corneal epithelial single cell strains can be obtained.

[0068] (6) The duck corneal epithelial single cell line was continuously subcultured to the 10th generation to obtain a line of adherent cultured duck corneal epithelial cells with uniform morphology.

[0069] 2. Construction of duck corneal epithelial cell suspension line

[0070] (1) Obtaining low-serum adherent culture type duck corneal epithelial cells: After the duck corneal epithelial cells in step 1 (6) grow into a monolayer, digest them with 0.25wt% EDTA-trypsin, and culture them in MEM medium containing 8v / v% fetal bovine serum. The culture conditions are 37°C and 5% CO2 incubator. After 5 consecutive generations of culture, culture them in MEM medium containing 6v / v% fetal bovine serum; after 5 consecutive generations of culture, culture them in MEM medium containing 3v / v% fetal bovine serum; after 5 consecutive generations of culture, low-serum adherent culture type duck corneal epithelial cells are obtained. The results are as follows Figure 1 shown.

[0071] (2) Obtaining duck corneal epithelial cell suspension cell line: After the low-serum adherent culture type duck corneal epithelial cells grew into a monolayer, they were digested with 0.25 wt% EDTA-trypsin, the cell suspension was collected, centrifuged at 800 rpm for 6 min, the supernatant was discarded, and the cell pellet was resuspended in serum-free suspension medium (BSL-01 medium, Guangzhou Baisai Biopharmaceutical Technology Co., Ltd.), and the cell density was adjusted to 1.0×10 6 cells / mL, culture conditions were 37°C, 5% CO2, 120r / min shaking. Samples were taken every 24 hours to observe cell morphology and count. After 3 days of culture, the cells were centrifuged and the medium was changed for subculture until the cell number of each generation was ≥6.0×10 6 cells / mL, the cells were stably and continuously cultured and subcultured to the 30th generation, and serum-free full suspension culture duck corneal epithelial cells, namely duck corneal epithelial cell suspension cell line, were obtained.

[0072] During the construction of the duck corneal epithelial cell suspension cell line, the cells were frozen every 5 passages to establish a cell bank.

[0073] The above-mentioned serum-free full suspension culture duck corneal epithelial cells were named duck corneal epithelial suspension cells DCE-S. When they were passaged to the 25th generation, they were preserved in the China Type Culture Collection at Wuhan University, Wuhan, China on June 28, 2024, with the preservation number CCTCC NO: C2024189. Figure 2 The results show the growth status of the 25th generation of corneal epithelial suspension cells DCE-S from the eyes of shelduck. Figure 3 This is the stable cell passage of different generations of duck corneal epithelial suspension cells DCE-S (F9~F30). The generation at the beginning of suspension culture is recorded as F1. From F9 to F30, the cell density of duck corneal epithelial suspension cells DCE-SD is stable at above 6.0×106cells / mL.

[0074] Example 2 Test on inoculation of duck corneal epithelial suspension cells DCE-S with H9 subtype avian influenza virus

[0075] The 25th generation of corneal epithelial suspension cells of duck eyes were cultured in a shaking incubator at 37°C, 5% CO2, and 120 rpm for 72 h. 6 cells / mL, add fresh culture medium to dilute the cells to 4×10 6 cells / mL, and inoculated with H9 subtype avian influenza virus (virus titer HA = 9log2, EID 50 =10 -8.0 / 0.1mL), and add TPCK trypsin with a final concentration of 5ug / mL, adjust the temperature to 35℃, culture for 72h, harvest the virus liquid, and detect HA. The results showed that the corneal epithelial suspension cells DCE-S of Mallard ducks were sensitive to H9 subtype avian influenza virus, with HA ≥ 9log2. Figure 4 This is the cytopathic effect image of the corneal epithelial suspension cells DCE-S of Mallard eyes inoculated with H9 subtype avian influenza virus for 72 hours. A large number of cells died and lysed, there were many cell fragments, and the number of live cells was significantly reduced.

[0076] The above strains have been disclosed in Qi, Xuefeng et al. "Down-regulation of cellular protein heme oxygenase-1 inhibits proliferation of avian influenza virus H9N2 inchicken oviduct epithelial cells." The Journal of general virology vol.99,1(2018):36-43.doi:10.1099 / jgv.0.000986.

[0077] Example 3 Test of duck corneal epithelial suspension cells DCE-S inoculated with duck circovirus (DuCV)

[0078] The 25th generation of corneal epithelial suspension cells of duck eyes were cultured in a shaking incubator at 37°C, 5% CO2, and 120 rpm for 72 h. 6 cells / mL, add fresh culture medium to dilute the cells to 4×10 6 cells / mL, and duck circovirus was inoculated at 5‰ v / v (virus titer TCID 50 =10 -6.0 / 0.1mL), adjust the temperature to 37°C, and harvest the virus solution after 60h of incubation. 50 The results showed that the corneal epithelial suspension cells DCE-S of shepherd's duck were sensitive to duck circovirus, TCID 50 ≥10 -7.0 / 0.1mL. Figure 5 This is the cytopathic effect image of the corneal epithelial suspension cells DCE-S of Mallard eyes inoculated with duck circovirus for 60 hours. A large number of cells died and lysed, there were many cell fragments, and the number of live cells was significantly reduced.

[0079] The above strains have been published in Xinyou et al. Establishment of a dual fluorescence quantitative PCR detection method for duck hepatitis A virus type 3 and duck circovirus [J]. Chinese Poultry.

[0080] Example 4 Test of duck corneal epithelial suspension cells DCE-S inoculated with duck Tembusu virus (DTMUV)

[0081] The 25th generation of corneal epithelial suspension cells of duck eyes were cultured in a shaking incubator at 37°C, 5% CO2, and 120 rpm for 72 h. 6 cells / mL, add fresh culture medium to dilute the cells to 4×10 6 cells / mL, and duck Tembusu virus was inoculated at 0.5‰ v / v (virus titer TCID 50 =10 -7.0 / 0.1mL), adjust the temperature to 37°C, and harvest the virus solution after 50h of incubation. 50 The results showed that the duck corneal epithelial cell suspension strain was sensitive to duck Tembusu virus, TCID 50 ≥10 -7.5 / 0.1mL. Figure 6 This is the cytopathic effect image of the corneal epithelial suspension cells DCE-S of Mallard eyes inoculated with duck Tembusu virus for 50 hours. A large number of cells died and lysed, there were many cell fragments, and the number of live cells was significantly reduced.

[0082] The above strains have been published in Zu Lichuang et al. Establishment and preliminary application of one-step RT-PCR detection method for duck Tembusu virus [J]. Guangdong Animal Husbandry and Veterinary Science and Technology, 2015 (Vol. 40), No. 5, 37-40.

Claims

1. A duck corneal epithelial cell line, named Duck Corneal Epithelial Suspension Cell DCE-S, was deposited in the China Type Culture Collection, Wuhan University, Wuhan, China on June 28, 2024, with the deposit number CCTCC NO: C2024189.

2. The method for constructing the duck corneal epithelial cell line according to claim 1, comprising the following steps: 1) Separate the eyeball of the duck embryo, separate the cornea, and cut it into tissue blocks; 2) Add the first culture medium, mix well, culture, and subculture for 5 to 15 generations; 3) Cultivate with the second culture medium and pass it for 3 to 5 generations; 4) using the third medium for culturing and subculturing for 3 to 5 generations; 5) Use the fourth medium for culturing and subculture for 3 to 5 generations. 6) Cultivate in serum-free suspension medium and subculture for 20 to 30 generations to obtain.

3. The construction method according to claim 2, characterized in that: The first culture medium comprises 8-10 v / v% fetal bovine serum and a basal culture medium; and / or The second culture medium comprises 6-8 v / v% fetal bovine serum and a basal culture medium; and / or The third culture medium comprises 4-6 v / v% fetal bovine serum and a basal culture medium; and / or The fourth culture medium includes 2-3 v / v% fetal bovine serum and a basal culture medium.

4. The construction method according to claim 3, characterized in that: The basic culture medium includes at least one of MEM culture medium, DMEM culture medium and DMEM / F12 culture medium.

5. Use of the duck corneal epithelial cell line according to claim 1 in any one of 1) to 8): 1) Cultivate the virus; 2) Preparation of products for cultured viruses; 3) Isolation of viruses; 4) Preparation of virus isolation products; 5) Virus testing for non-diagnostic treatment destinations; 6) Preparation of products for detecting viruses; 7) Preparation of viral vaccines; 8) Drug screening; The medicine is a medicine used for preventing or treating diseases caused by viral infection.

6. The use according to claim 5, characterized in that: The virus includes at least one of avian influenza virus, duck circovirus, and duck Tembusu virus.

7. A method for culturing a virus, comprising inoculating the virus into the duck corneal epithelial cell line of claim 1 and culturing the cell.

8. A method for preparing a virus vaccine, comprising inoculating the virus into the duck corneal epithelial cell line of claim 1, culturing, and inactivating the virus to obtain the virus vaccine.

9. The method according to claim 7 or 8, characterized in that: The virus includes at least one of avian influenza virus, duck circovirus, and duck Tembusu virus.

10. A viral vaccine prepared by the method of claim 8 or 9.

Citation Information

Patent Citations

  • Cherry valley duck embryo epithelial cell line and establishment method thereof

    CN103725644A

  • Triple inactivated vaccine for Newcastle disease, H9 subtype avian influenza and avian adenovirus

    CN112294952A

  • Goose retina epithelial cell line as well as construction method and application thereof

    CN114107171A

  • Cherry valley duck fibroblast cell line as well as construction method and application thereof

    CN114350601A

  • Suspension domestication method and application of shelduck embryo liver mesenchymal stem cells

    CN114540292A